Healing Stigma Through Stories

July 10, 2026 updated by: Li-Ting Huang, National Yang Ming Chiao Tung University

Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia

This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.

A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 years or older.
  • Diagnosed with schizophrenia or schizoaffective disorder.
  • Clinically stable at the time of study enrollment.
  • Able to communicate in Mandarin Chinese or Taiwanese.
  • Able to read and write and complete study questionnaires.

Exclusion Criteria:

  • Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
  • Unwilling to have the intervention sessions audio-recorded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healing Stigma through Stories
Four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Internalized Stigma of Mental Illness Scale
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Beck Depression Inventory-II
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks
Self-Reported Graphic version of the Personal and Social Performance Scale
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks
Subjective Happiness Scale
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks
Herth Hope Index
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks
The questionnaire about the process of recovery
Time Frame: At baseline(T0) and through study completion, an average of 8 weeks
At baseline(T0) and through study completion, an average of 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

July 7, 2026

First Submitted That Met QC Criteria

July 10, 2026

First Posted (Actual)

July 16, 2026

Study Record Updates

Last Update Posted (Actual)

July 16, 2026

Last Update Submitted That Met QC Criteria

July 10, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NYCU115040AF
  • 115-2314-B-A49 -082 - (Other Grant/Funding Number: National Science and Technology Council)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia / Schizoaffective Disorder

Clinical Trials on Healing Stigma through Stories

Subscribe